Category: Medicine

As Skye embarks on their CBeyond phase 2 clinical trial, we explore the motivation, methodology, and expected outcomes of incorporating…

James, who joined Qinecsa three years ago after stints at Genpact and Accenture, discussed the company’s mission, products, and the…

This funding will be distributed over two years to four pioneering research projects that emerged from the Tauopathy Challenge Workshop.…

This article features insights from leading experts at CAI, including Alice Redmond, Harry Benson, Jonathan Thompson, and David Shenberger. They…

The organizations say this collaboration uses the strengths of both to create a cutting-edge platform designed to uncover new insights…

As a 501(c)(3) nonprofit organization​, BHC has made significant strides in addressing chronic health challenges that affect millions of people…

These internet-based solutions are designed to support patients with social anxiety disorder, post-traumatic stress disorder (PTSD), and anxiety disorders in…

Finding herself on a pediatric ward something inside her changed and she became determined to do something to help the…

For the first time, revenue earned from innovation programs has surpassed that from generic projects. Over the past five years,…

Clark highlights several key trends and advancements shaping the industry today. The explosion of data and complexity Clark opens the…

The E6(R3) Guideline for Good Clinical Practice revises ICH E6(R2) and is expected to go live in 2025. To understand…

To gain insight into this complex landscape, we spoke with Abbas Razvi, head of pharmaceutical development, and Sandro Holzer, head…

With an inquisitive mind and by asking endless questions, she soon found herself studying medicine and fully understanding what her…

Clark highlights several key trends and advancements shaping the industry today. The explosion of data and complexity Clark opens the…

On Friday (July 26), the European Union’s drugs regulator, the Committee for Medicinal Products for Human Use (CHMP), advised that…

By creating a future of cheaper and faster studies, these innovations are paving the way for more targeted treatments and…

The move was made to help free up access to care for patients across pharmacies and dental practices and to…

This SaaS-based solution simplifies the workflow for clinical trial site staff, enabling them to focus more on patient care and…

At the Alzheimer’s Association International Conference, experts from the Emmes Group discussed the impact of this new therapy on the…

Bellamy, who joined Qinecsa three years ago after stints at Jam Packs and Accenture, discussed the company’s mission, products, and…

In this exclusive interview, they share insights into their mission to decode exceptional cancer survival cases, their innovative methodologies, and…

The deal, which was financed by cash and debt financing, is due to close before 2025 and will see BIOVECTRA…

Third Arc Bio has announced the closing of a $165 million series A round led by Vida Ventures and co-led…

This significant milestone, achieved following a comprehensive five-day on-site inspection from April 29 to May 3, 2024, marks a critical…

Her journey in life sciences began with a deep childhood curiosity about the natural world, leading to a career in…

From asking endless questions about the causes of illness as a young girl to pioneering therapeutic innovations as an adult,…

The findings come from the HIV Prevention Trials Network (HPTN) 084 open label extension (OLE) study, which evaluated cis-gender women…

Her leadership encompasses visionary support, development, and advocacy for FIP’s 144 member organizations, representing four million members globally. Dr. Duggan’s…

This partnership aims to revolutionize the understanding and treatment of various tremor conditions, using the combined expertise of both organizations…

The expansion will cover existing facilities as well as brand new constructions. CordenPharma aims for all its facilities to meet…

Genentech, a Roche Group member, announced​ this week that its investigational oral, glucagon-like peptide-1 (GLP-1) receptor agonist CT-996 showed good…

The manufacturing and regulatory process of biopharmaceuticals is highly complex and costly to implement, which can be challenging for big…

The companies will jointly control Cosette, with a focus on accelerating innovation and growth. Since Avista’s initial investment in Cosette…

This marks the third FDA approval for Voquenza, which is also approved for treating all severities of Erosive Esophagitis (EE),…

She has a PharmD-PhD in Medical Physics and is a seasoned professional with a deep understanding of healthcare, law, and…

With an impressive career spanning 35 years in the healthcare industry, Fathallah shares his vision for the future of DIA…

This significant project is set to create 232 jobs in Pitt County and marks a milestone in Nipro’s expansion into…

This state-of-the-art facility not only doubles IDT’s production capacity but also introduces cutting-edge technologies and energy-efficient measures to enhance gene…

By leveraging diverse data sources and advanced analytics, the company says it empowers the healthcare continuum to make informed clinical…

This accomplishment highlights the company’s creative approach and steady march towards completing 15 harvests within the calendar year. With its…

Investment in psychedelic drugs started booming in 2020. The lockdowns brought by the Covid-19 pandemic highlighted the importance of mental…

In an insightful interview, Tim Martin, vice president, product, at Yseop, discusses the company’s recent advancements, notable collaborations, and the…

This innovation is poised to transform patient access to cancer care by leveraging advanced AI capabilities to provide personalized treatment…

Her insights, captured in the white paper “Closing the Gap in Our Understanding of Sleep Health with Fit-for-Purpose Wearable Digital…

Tyra Biosciences has released positive results from a preclinical proof of concept study testing its lead drug candidate, TYRA-300, in…

Industry leaders give their takes on what else is in store for AI-based tools in the pharma space. AI-powered algorithms…

Bakshi shares the innovative approach of YCT-529, the results of their Phase 1a study, and the anticipated impact on reducing…

 In this interview, she shares insights into her role, personal journey, challenges faced, and advice for aspiring women in science.…

This Q&A with Sheeba Ibidunni, public health expert and the VP of operations ​at Sonara Health explores the socio-economic factors fuelling…

The initiative seeks to understand the crucial role of the omentum, a lesser-known yet vital organ in cancer treatment and…

The IP-protected CBD intermediate brings superior functionality allowing for a higher drug loading compared to currently commercially available products, paving…

With a lot of familial inspiration, an early love of science developed for Pam James, here we find out how…

Ginny brings a wealth of knowledge and experience to the table from her diverse background in nursing, law, and regulatory…

Eli Lilly has entered a strategic partnership with Radionetics Oncology, a biotechnology company focusing on the discovery and development of…

The deal was supported by Keensight Capital, a private equity manager focusing on pan-European investments in the technology and healthcare…

Tyra Biosciences has released positive results from a preclinical proof of concept study testing its lead drug candidate, TYRA-300, in…

Her insights, captured in the white paper “Closing the Gap in Our Understanding of Sleep Health with Fit-for-Purpose Wearable Digital…

The construction project will be financed until 2026 by a €100 million ($108 million) investment by the company. The facilities,…

Results from the PARADIGM clinical trial have revealed that PrimeC, a treatment being developed by NeuroSense Therapeutics, was able to…

This collaboration aims to unite experts from various fields to explore how emerging protein science can address the challenges in…

YonaLink, a pioneering company in digital healthcare, is set to change that. In an in-depth interview with senior editor, Liza…

Also known as precision medicine, this kind of individualized treatment is designed specifically for the patient and has revolutionized cancer…

These efforts are driven by the need for transparency, compliance, and sustainability in response to pressures from stakeholders, including investors,…

This groundbreaking approval is expected to transform the market for patients suffering from moderate to severe exacerbations, particularly those with…

Check out five upcoming AI players attracting investor attention for their potential to speed up drug discovery. Drug discovery is…

YonaLink, a pioneering company in digital healthcare, is set to change that. In an in-depth interview with senior editor, Liza…

In an interview with Biopharma Reporter, Mainz Biomed CEO Guido Baechler explains how his company’s stool test for colorectal cancer…

This expansion, one of the largest in the company’s history, aims to enhance the production of injectable treatments for obesity…

Ginny brings a wealth of knowledge and experience to the table from her diverse background in nursing, law, and regulatory…

With his background in psychiatry, Michael observed the daily struggles of patients in Opioid Treatment Programs and developed Sonara to…

The expansion will introduce 200,000 sq. ft. of additional space, addressing the growing demand for Grade-A facilities amid a rising…

In a groundbreaking development, Systech, a subsidiary of Markem-Imaje and Dover, has introduced a turnkey manual aggregation and rework solution…

CluePoints is a cloud-based software platform specializing in Risk-Based Quality Management (RBQM) and data quality oversight in clinical trials. The…

This guideline, which ensures regulatory compliance with the requirements of ICH GCP E6, came into effect on 9 September 2023.…

IQVIA recognized the intricate challenges associated with participant payments in clinical trials, which often involve cumbersome processes and multiple vendors,…

In an interview with Biopharma Reporter, Mainz Biomed CEO Guido Baechler explains how his company’s stool test for colorectal cancer…

The panel featured Ariel Berger, executive director of integrated solutions and real-world evidence at Aventura; John Van Hoy, executive director…

Last year, Astellas Pharma established a behavioral science consortium to perform research aimed at better understanding what matters to patients…

This first-of-its-kind phase 2 grant will expedite the commercialization of cannabinoid ingredient production via precision fermentation. The funding aims to…

This key study explores the influence of CYP2C9 genetic polymorphisms on the pharmacokinetics (PK) of delta-9-tetrahydrocannabinol (THC) and its active…

The conversation delves into the complexities of signal management in the PV landscape, highlighting recent advancements and the challenges faced…

CluePoints is a cloud-based software platform specializing in Risk-Based Quality Management (RBQM) and data quality oversight in clinical trials. The…

This guideline, which ensures regulatory compliance with the requirements of ICH GCP E6, came into effect on 9 September 2023.…

This expansion of Thermo Fisher’s clinical trial network in Europe will help foster global clinical trial innovation and provide biorepository…

This key study explores the influence of CYP2C9 genetic polymorphisms on the pharmacokinetics (PK) of delta-9-tetrahydrocannabinol (THC) and its active…

This new medication, approved by the US FDA in October 2023, combines 1,000 mg of acetaminophen and 300 mg of…

Spectrum supports study teams by providing real-time predictions and control over trial timelines and costs, ensuring successful trials in today’s…

This key study explores the influence of CYP2C9 genetic polymorphisms on the pharmacokinetics (PK) of delta-9-tetrahydrocannabinol (THC) and its active…

However, the eCOA/ePRO market has seen minimal innovation since the transition from paper-based forms to digital formats two decades ago,…

However, the eCOA/ePRO market has seen minimal innovation since the transition from paper-based forms to digital formats two decades ago,…

Promising to redefine the landscape with its latest solutions, the company hopes to take center stage, offering advancements in data…

John Romano, president, and co-founder, shares exclusive insights into how these innovations are set to tackle industry challenges and enhance…

This was to discuss what they describe as the groundbreaking impact of their Sub-population Optimization & Modeling Solution (SOMS). This…

Advarra is set to reveal solutions tailored to address current challenges in the pharmaceutical and healthcare industries. With the results…

This innovative technology allows study teams to predict, optimize, and control trial timelines and costs in real-time, enabling iterative feasibility…

The center, envisioned as a hub for groundbreaking research and development in pharmaceutical sciences, has thus far successfully lived up…

Enter Stardog, an AI and data startup at the forefront of revolutionizing how drugs are brought to market. As pharmaceutical…

FDA and its stakeholders have a vested interest in ensuring the integrity of clinical trial data and the safety of…

He says the strategic expansion into continuous manufacturing facilities aims to revolutionize the accessibility and affordability of life-saving medicines. LL:…

Diane shares her expert insights on how creative data solutions are transforming the landscape of clinical research, enhancing efficiency, and…

This endorsement comes from the phase 3 March study showing a highly significant reduction in pruritus severity compared to placebo…

The big announcement was made at the BIO International Convention, where top policy and health leaders gathered to discuss the…

Established in the 1990s by a group of professors including the renowned Yoshua Bengio, and Laurent Tillement, OSP was delighted…

Christine Allen, a veteran with 25 years in drug formulation, is at the forefront of this breakthrough. She says Intrepid…

The company says its mission is geared towards enhancing clinical research site performance and participant satisfaction. This prestigious accolade recognizes…

Following the signing of an introductory sales contract with a long-established American business, Celadon has successfully shipped two different medical…

Coming from Donegal in the northwest of Ireland, where there isn’t much industry to a more than 20 years supporting…

Cybin is driven by engineering proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches – developing differentiated next-generation psychedelic therapeutics…

Cybin is driven by engineering proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches – developing differentiated next-generation psychedelic therapeutics…

This strategic acquisition, valued at approximately SEK 11.8 billion (around $1.1 billion), aims to make Calliditas a wholly owned subsidiary,…

According to the report, the race to create antibiotics and antifungals to conquer superbugs is falling perilously short, which the…

The recent financing boosts Bicycle Therapeutics’ balance sheet, bringing the pro forma cash position to approximately $1 billion. This financial…

This funding surge comes as the company continues to advance the application of generative AI through its platform, Geneva OS.…

It has achieved this with the acquisition of Pharma Consulting Group S.A., the holding company of Laboratorios Biopas SA. This…

Detailed results from studies Oasis 1 and 2 will be showcased at the 2024 ACOG Annual Clinical & Scientific Meeting…

She has a PharmD-PhD in Medical Physics and is a seasoned professional with a deep understanding of healthcare, law, and…

The survey included 127 pharmaceutical sponsor respondents and 79 research site respondents, analyzing their perspectives working together on site feasibility…

The association says the day (May 20) is a ‘joyful opportunity to pause in reflection, recognition, and admiration of all…

This round was led by new investor Questa Capital, with participation from existing investors Vive Collective and South Park Commons.…

One2Treat aims to make the clinical trial process as seamless as possible and answered a number of the questions we…

Samuel Poulin, presented Install-VASc and shared his insights into another innovative project aimed at transforming ultrasound-guided catheter insertion, highlighting the…

According to the report, the race to create antibiotics and antifungals to conquer superbugs is falling perilously short, which the…

Here she explains all about the challenges and triumphs that saw her reach her position of chief medical officer at…

This round was led by new investor Questa Capital, with participation from existing investors Vive Collective and South Park Commons.…

Durect Corporation is a late-stage biopharma company championing the development of epigenetic therapies to transform the treatment of serious and…

This significant 510(k) clearance permits the use of HALO AP Dx in conjunction with the Hamamatsu NanoZoomerS360MD Slide scanner for…

She has a PharmD-PhD in Medical Physics and is a seasoned professional with a deep understanding of healthcare, law, and…

BPR: What new products or innovations is Novartis showcasing at BIO 2024 this year?​ At BIO 2024, Novartis Contract Manufacturing…

BPR: What new products or innovations is your company showcasing at BIO 24?​ This year, we’re showcasing our fully integrated,…

BPR: What new products or innovations is Cytiva showcasing at BIO 2024 this year?​ BIO is a very important convention…

BPR: What new products or innovations is your company showcasing at BIO 2024 this year? ​ This year we are delighted to…

BPR: What new products or innovations is Abzena showcasing at BIO 2024 this year?​ Abzena has recently launched our AbZelect and…

Detailed results from studies Oasis 1 and 2 will be showcased at the 2024 ACOG Annual Clinical & Scientific Meeting…

While antimicrobial resistance is on the rise, a greater number of people still succumb to infections caused by drug-sensitive bacteria.…

The drug, SRP-001’s promising results from its phase 1 trial were also published. The announcement was made by South Rampart…

The goal is to propel clinical trials aimed at speeding-up the diagnosis and treatment of ME/CFS and long COVID patients. The…

Presented at ISPOR 2024, the findings emphasize the need for integrating patient needs and preferences into strategies for managing unhealthy…

The company says its new product, built on its advanced Lycagel pea starch technology, offers manufacturers the freedom to select…

This official launch marks a significant advancement in patient care in mainland China, introducing a new era in the treatment…

This move is part of a larger €3.5 billion program within the country.  The investment will be allocated to facilities…

Brian Hashemi, executive chairman and CEO of Novigenix, and Sabine Tejpar, founder of the IMMUcan Consortium, are leading this collaborative…

The Virginia-based company has revealed promising results from its phase 1b clinical trial assessing RDX-002, a novel small molecule therapy…

The money is to support the development of breath-based diagnostics for infectious diseases. The funding comprises a $5 million equity…

Yesterday, (April 29), during a packed program of events, OSP was invited to watch presentations from four startups nurtured by…

This offering aims to streamline the identification of synthetic routes for novel active pharmaceutical ingredients (APIs) by using Lonza’s extensive…

Titled ‘State of the Discovery Nation (SODN) 2024: Fostering a Dynamic, Sustainable Medicines Discovery Sector,’ the report published in conjunction…

The agreement, announced today, underscores Shionogi’s dedication to expanding its pipeline in the rare disease domain. According to the National…

This first-in-human study aims to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of NBI-1117567 in healthy adult participants. The compound,…

As Mental Health Awareness Week 2024 approaches, employers must recognize the power of data in improving staff wellbeing. Peter Taylor,…

This week the second in the series comes from Jonathan Boudreau, a co-founder of Displaid and a finalist in the…

Having been originally interested in engineering, she soon realized that path was not the best for the set of skills…

This initiative will integrate select Walgreens community pharmacies as clinical trial sites, focusing on phase 3 trials for individuals grappling…

The ongoing construction and validation activities mark a significant step in the company’s ambitious $100 million capital investment project, tipped…

Inizio Engage, a life science consulting firm, is aiming to address this challenge through its data-driven and evidence-based methodology. During…

LGM Pharma, under Raje’s visionary stewardship, has undergone a remarkable journey of expansion and transformation since its acquisition by New…

Using artificial intelligence (AI), genetic engineering, and robotics, the company said it proudly introduces the world’s first automated animal research…

Starting on May 27 in London, this practitioner program is designed for healthcare professionals and students in professional training who…

However, Canadian company Organon wants to change this, a spin off from Merck & Co., Inc., it has a mission to focus…

However, Canadian company Organon wants to change this, a spin off from Merck & Co., Inc., it has a mission to focus…

The money is to support the development of breath-based diagnostics for infectious diseases. The funding comprises a $5 million equity…

BPR: Could you give us an overview of your work?​ I joined Calliditas Therapeutics as CEO in 2017, and in…

Yesterday, (April 29), during a packed program of events, OSP was invited to watch presentations from four startups nurtured by…

This offering aims to streamline the identification of synthetic routes for novel active pharmaceutical ingredients (APIs) by using Lonza’s extensive…

Wendy specializes in applying advanced methodologies to address complex healthcare research challenges and has used machine learning and other predictive…

The Virginia-based company has revealed promising results from its phase 1b clinical trial assessing RDX-002, a novel small molecule therapy…

BPR: What new products or innovations is your company showcasing at CPHI North America this year?​ We are a CMO…

“The extended approval allows enzalutamide to be administered either as monotherapy or in combination with androgen deprivation therapy (ADT) for…

She works as joint chief operating officer at a specialist biometrics CRO called Quanticate where she looks after the programming and…

We caught up with the company once more and put a few more questions to CEO Sebastian Coppe about the…

Inizio Engage, a life science consulting firm, is aiming to address this challenge through its data-driven and evidence-based methodology. Duering…

LGM Pharma, under Raje’s visionary stewardship, has undergone a remarkable journey of expansion and transformation since its acquisition by New…

It has been widely reported that in early February US intelligence officials told senators working on a biotech security bill,…

OSP caught up with them before the event, which is taking place in the Pennsylvania Convention Center, Philadelphia, between May…

The company says its renowned ImmunoINSIGHTS platform is recognized for its prowess in antibody marker discovery and will now be…

The collaboration marks a significant stride towards shifting symptom assessment paradigms in Rett syndrome through the use of cutting-edge wearable…

This achievement marks a significant milestone in the company’s journey, granting European Union medical providers access to a life-saving device…

It is now poised to become the first facility in the United States dedicated to producing wearable rings.  This strategic move…

BPR: What new products or innovations is your company showcasing at CPhI North America this year? ​ With the new acquisitions…

BPR: Can you provide insights into any regulatory changes or compliance issues that are impacting your business?​ Our new APS-qualified…

These findings, set to be showcased at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global event in…

Mainz Biomed has been manufacturing ColoAlert which is a non-invasive mt-stool DNA screening test designed for early detection of cancer.…

The company said its project represents a significant investment of $200 million over the past four years, with an additional…

The company was founded by healthcare technology startup veteran John Romano, and the company launched a pilot program in Ohio…

As the company will be attending CPhI North America, OSP caught up with Hamilton Lenox, senior vice president of business…

As chief delivery officer, biometrics services at eClinical Solutions, Katrina is driving clinical data transformation, and building a thriving services…

Following on from this news​, OSP put several questions to the pharma giant to dig deeper into the study. Can…

The state-of-the-art facility will be an innovation and co-creation/working lab that supports the creation, testing, and validation of new services…

In her current role as senior director of integrated pharmacovigilance (PV) solutions, she provides senior leadership and oversight to the…

The project represents a significant investment of $200 million over the past four years, with an additional $300 million earmarked…

This strategic move, the company says, aligns with Qinecsa’s vision to emerge as the premier provider of digital pharmacovigilance solutions.…

The successful completion of the preclinical toxicity program for NBI-1117568, an oral M4 receptor agonist, marks a crucial step in…

OSP spoke to Frontsin about why the CROs are under greater pressure to deliver measurable results quickly at lower costs.  He…

Leniolisib, marketed as Joenja in the US, obtained FDA approval in March 2023 for treating APDS in adult and pediatric…

The investment will accelerate the development of D3 Bio’s pipeline of oncology compounds, particularly its lead asset DS3-001. D3S-001 is…

Prenosis, a player in the realm of health technology, has secured this milestone with the full authorization of its diagnostic…

Founded in 2018 by a group of industry veterans with diverse expertise, the company has swiftly carved a niche for…

The National Institute for Health and Care Excellence (NICE) has endorsed atogepant, a novel oral medication, as a preventive treatment…

This was announced yesterday (April 12) by the executive officer, Isao Teshirogi, of Shionogi BV, the European subsidiary of Shionogi…